Berta Puig

Lipid Alterations in Lipid Rafts from Alzheimer's Disease Human Brain Cortex

Noemí Fabelo, Gabriel Santpere, Berta Puig et al. · Journal of Alzheimer s Disease · 2010 · 276 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

Phosphorylated Map Kinase (ERK1, ERK2) Expression is Associated with Early Tau Deposition in Neurones and Glial Cells, but not with Increased Nuclear DNA Vulnerability and Cell Death, in Alzheimer Disease, Pick's Disease, Progressive Supranuclear Palsy and Corticobasal Degeneration

Isidró Ferrer, Rosa Blanco, Margarita Carmona et al. · Brain Pathology · 2001 · 237 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies

Isidró Ferrer, Rosa Blanco, Margarita Carmona et al. · Journal of Neural Transmission · 2001 · 204 citations

Life Sciences, Neurobiology, Neuroscience +17

Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration

Isidró Ferrer, Marta Barrachina, Berta Puig · Acta Neuropathologica · 2002 · 192 citations

Life Sciences, Neurology, Neuroscience +16

Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models

Isidró Ferrer, Marta Barrachina, Berta Puig et al. · Neurobiology of Disease · 2005 · 175 citations · Full text

Life Sciences, Genetics, Neuroscience +14